Preparation method of dandelion granules and related products thereof
By using alkaline amino acids and phenolic acid components in dandelion granules to form salts, combined with ethanol granulation and drying processes, the problem of unstable phenolic acid components in dandelion granules is solved, and the stability and antibacterial activity are significantly improved. .
Patent Information
- Application Number
- CN202411143661.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-20
- Publication Date
- 2024-11-26
AI Technical Summary
The phenolic acid components in dandelion granules are unstable and easy to decompose, which affects its widespread use.
Using alkaline amino acids such as arginine and histidine as auxiliary materials to form salts with phenolic acid components in dandelions, combined with ethanol granulation and drying processes, improve the stability of phenolic acid components, and add anti-crystallization if necessary Agents such as xanthan gum are used to prevent crystallization.
It significantly improves the stability of phenolic acid components in dandelion granules and enhances its antibacterial activity. Especially through the use of arginine and histidine, the stability of phenolic acid components is significantly improved, and the drying process ensures The integrity of the granules.
Abstract
Description
Technical Field
[0001] The invention relates to a preparation method of dandelion particles and related products thereof, belonging to the field of traditional Chinese medicine preparations. Background Art
[0002] Dandelion is the dried whole herb of Taraxacum mongolicum Hand.-Mazz., Taraxacum borealisinense Kitam. or several plants of the same genus in the Asteraceae family. It is bitter, sweet, and cold, and enters the liver and stomach meridians. It has the effects of clearing away heat and detoxifying, reducing swelling and dispersing nodules, and promoting diuresis and relieving stranguria.
[0003] Dandelion granules are recorded in the eighth volume of the Ministry of Health's drug standard Chinese medicine formula preparations. The preparation method is to take dandelion medicinal materials, add water and boil twice, combine the filtrate, filter, and concentrate the filtrate to a clear paste with a relative density of 1.32-1.35 (measured at 80-85℃). Add sucrose powder to 1 part of the clear paste and 5 parts of sucrose powder to make granules, dry them, and you're done. It is mainly used for antibacterial and anti-inflammatory treatment of upper respiratory tract infections, acute tonsillitis, and mastitis.
[0004] With the deepening of research in modern natural drug chemistry and pharmacology, the main active ingredients of dandelion granules have gradually been identified. As for the antibacterial and anti-inflammatory effects, it may be related to the phenolic acid components (such as caffeic acid, chlorogenic acid, etc.) and flavonoid components (such as luteolin) in dandelion.
[0005] As for phenolic acid components such as caffeic acid and chlorogenic acid, they are relatively unstable in granules and easily decomposed when exposed to light or heat. Therefore, this has always been an important technical issue that has plagued the widespread application of dandelion granules and needs to be resolved in subsequent research. Summary of the invention
[0006] The first aspect of the present invention is to provide a method for preparing dandelion granules, comprising:
[0007] 1) Take dandelion medicinal material, crush it, boil it with 12 times the volume of water for 2 hours, filter the decoction, add 10 times the volume of water for the second time, boil it for 2 hours, filter the decoction, and combine the two filtrates;
[0008] 2) Add amino acids to the filtrate and stir evenly; let it stand for 2 hours, filter and concentrate to a clear paste with a relative density of 1.32 to 1.35 (measured at 80 to 85°C).
[0009] 3) Add 5 parts of sucrose powder to 1 part of clear paste, granulate with ethanol, send the wet granules into a granulating dryer for drying, and the whole granules are obtained.
[0010] In one embodiment, the amino acid is one or more of arginine, histidine and lysine.
[0011] In a further embodiment, the amino acid is arginine or histidine. The weight ratio of the amino acid to the dandelion medicinal material is 0.01-1%, preferably, the weight ratio of the amino acid to the dandelion medicinal material is 0.05-0.1%.
[0012] In another embodiment, in step 2), an anti-crystallization agent is added simultaneously with the addition of the amino acid.
[0013] In a further embodiment, the anti-crystallization agent is xanthan gum. The weight ratio of the anti-crystallization agent to the amino acid is 1:0.5-2; preferably 1:1.
[0014] The second aspect of the present invention is to provide dandelion granules obtained by the preparation method.
[0015] The third aspect of the present invention is to provide the use of the dandelion granules in the preparation of antibacterial and anti-inflammatory drugs.
[0016] The present invention finds that by using basic amino acids as auxiliary materials to form salts with phenolic acid components in dandelions, the stability of phenolic acid components can be greatly improved, while the effect of forming sodium salts through sodium hydroxide is significantly lower than that of basic amino acids. In addition, while improving the stability of dandelion granules, it is unexpectedly found that the antibacterial activity of the dandelion granules is also significantly improved, which may be related to the salt formation of phenolic acid components and basic amino acids, or may be related to the synergistic effect of specific amino acids and certain active ingredients in dandelions. Further mechanism needs to be clarified by subsequent research. DETAILED DESCRIPTION
[0017] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative work are within the scope of protection of the present invention.
[0018] Example 1 Screening of auxiliary materials for dandelion granules
[0019] Take 1 kg of dandelion medicinal material, crush it through a 40-mesh sieve, and boil it with 12 times the volume of water for 2 hours for the first time. Filter the decoction and set aside; add 10 times the volume of water for the second time, boil it for 2 hours, filter the decoction, combine the two filtrates and set aside.
[0020] Group 1: Take part of the filtrate, add arginine (the amount added is 0.1% of the amount of crude drug corresponding to the filtrate), stir evenly; let it stand for 2 hours, filter and concentrate to a clear paste with a relative density of 1.32-1.35 (measured at 80-85°C).
[0021] Group 2: Take part of the filtrate, add histidine (the amount added is 0.1% of the amount of crude drug corresponding to the filtrate), stir evenly; let it stand for 2 hours, filter and concentrate to a clear paste with a relative density of 1.32-1.35 (measured at 80-85°C).
[0022] Group 3: Take part of the filtrate, add lysine (the amount added is 0.1% of the amount of crude drug corresponding to the filtrate), stir evenly; let it stand for 2 hours, filter and concentrate to a clear paste with a relative density of 1.32-1.35 (measured at 80-85°C).
[0023] Group 4: Take part of the filtrate, add sodium hydroxide thereto, adjust the pH value to 7.0; let it stand for 2 hours, filter and concentrate to a clear paste with a relative density of 1.32 to 1.35 (measured at 80 to 85°C).
[0024] Group 5: Take part of the filtrate, add sodium hydroxide thereto, adjust the pH value to 7.0; and add PBS buffer with a pH value of 7.0, the volume ratio of PBS buffer to filtrate is 0.1:1, let it stand for 2 hours, filter and concentrate the filtrate to a clear paste with a relative density of 1.32-1.35 (measured at 80-85°C).
[0025] Group 6: Take part of the filtrate and directly concentrate it to a clear paste with a relative density of 1.32-1.35 (measured at 80-85°C).
[0026] Add sucrose powder to each of the above-mentioned clear pastes according to the ratio of 1 part of clear paste to 5 parts of sucrose powder, granulate with ethanol, send the wet granules into a granulating dryer for drying at a material temperature of 60-80°C, dry, and obtain granules.
[0027] The above groups of granules were subjected to stability tests (3 months) under high temperature and high humidity conditions (temperature of 45°C ± 2°C, relative humidity of 75% ± 5% RH), and then the contents of chicoric acid, caffeic acid, chlorogenic acid and luteolin in the dandelion granules were determined according to the method disclosed on page 368 of Part I of the 2020 edition of the Chinese Pharmacopoeia. The specific results are as follows:
[0028] mg / g moon Chicoric acid Caffeic acid Chlorogenic acid Luteolin Group 1 0 5.14 0.76 0.98 0.11 3 5.09 0.75 0.95 0.10 Group 2 0 5.17 0.78 0.96 0.13 3 5.12 0.76 0.96 0.12 Group 3 0 5.08 0.74 0.93 0.09 3 5.01 0.72 0.90 0.05 Group 4 0 5.18 0.77 0.94 0.08 3 4.91 0.66 0.91 0.05 Group 5 0 5.09 0.72 0.90 0.11 3 4.87 0.60 0.88 0.06 Group 6 0 5.15 0.79 1.01 0.10 3 4.83 0.62 0.81 0.09
[0029] From the above results, it can be seen that the use of basic amino acids as stabilizers for phenolic acid active ingredients in dandelion granules can greatly improve the stability of such ingredients, and its mechanism of action may be related to the salt formation of basic amino acids and phenolic acid ingredients. However, for lysine in group 3, although phenolic acid ingredients are relatively stable, the stability of flavonoid ingredient luteolin is greatly reduced. Therefore, arginine and histidine have good application prospects as stabilizers.
[0030] In addition, this example also uses a pH adjustment method to examine the effect on the dandelion granules, hoping to improve the stability of phenolic acid components by forming sodium salts of such components. However, from the above results, this method only significantly improves the stability of chlorogenic acid, but not the stability of chicoric acid, caffeic acid and luteolin. Moreover, on this basis, the addition of a pH stabilizer does not have any effect on improving stability.
[0031] Example 2 Amino Acid Dosage Screening
[0032] According to the method of Example 1 Group 1, 0.05% and 0.2% arginine of the corresponding crude drug amount were added to the filtrate, and the remaining granule preparation methods were the same as those of Example 1 Group 1; then stability experiments were carried out and tested, and the specific results were as follows:
[0033] mg / g moon Chicoric acid Caffeic acid Chlorogenic acid Luteolin 0.05% group 0 5.15 0.78 1.01 0.13 3 5.11 0.77 0.99 0.12 0.2% group 0 5.18 0.79 0.98 0.12 3 5.16 0.72 0.96 0.08
[0034] From the above results, it can be seen that the 0.05% group has significantly improved the stability of phenolic acid components and luteolin; the effect of the 0.2% group on phenolic acid components is not much different from that of the 0.05% group, but the stability of luteolin is significantly reduced, indicating that the best effect is achieved when the amount of amino acids is between 0.05-0.1%.
[0035] Example 3 Screening of anti-crystallization auxiliary materials
[0036] During the preparation process of the dandelion granules with added amino acids in Example 1 and Example 2, it was found that obvious crystals appeared in the clear paste when it was concentrated to a clear paste. It is speculated that the reason may be related to the salt formation of phenolic acid components and basic amino acids, which will undoubtedly affect the dispersion uniformity of the active ingredients of the granules. Therefore, it is necessary to consider adding a certain amount of anti-crystallization agent to the granules to overcome this defect.
[0037] The specific method is: taking Group 1 of Example 1 as an example, while adding arginine, equal amounts of PEG400, HPMC and xanthan gum are added at the same time, and the other preparation methods are the same as Group 1 of Example 1, and then observing whether crystals appear in the clear paste.
[0038] The results showed that PEG400 and HPMC had no significant improvement on the crystallization phenomenon in the clear paste, while xanthan gum could effectively inhibit the crystallization phenomenon.
[0039] Example 4 Preparation of Dandelion Granules
[0040] Take 1 kg of dandelion medicinal material, crush it through a 40-mesh sieve, and boil it with 12 times the volume of water for 2 hours for the first time. Filter the decoction and set aside; add 10 times the volume of water for the second time, boil it for 2 hours, filter the decoction, combine the two filtrates and set aside.
[0041] Add 1 g of arginine and 1 g of xanthan gum to the filtrate and stir evenly; let it stand for 2 hours, filter and concentrate to 151.3 g of a clear paste with a relative density of 1.32 to 1.35 (measured at 80 to 85°C).
[0042] Add sucrose powder to 5 parts of 1 part of clear paste, granulate with ethanol, send the wet granules into a granulating dryer for drying, the material temperature is 60-80℃, dry, and obtain whole granules.
[0043] Example 5 Preparation of Dandelion Granules
[0044] Take 1 kg of dandelion medicinal material, crush it through a 40-mesh sieve, and boil it with 12 times the volume of water for 2 hours for the first time. Filter the decoction and set aside; add 10 times the volume of water for the second time, boil it for 2 hours, filter the decoction, combine the two filtrates and set aside.
[0045] Add 1 g of histidine and 1 g of xanthan gum to the filtrate and stir evenly; let it stand for 2 hours, filter and concentrate to 149.6 g of a clear paste with a relative density of 1.32 to 1.35 (measured at 80 to 85°C).
[0046] Add sucrose powder to 5 parts of 1 part of clear paste, granulate with ethanol, send the wet granules into a granulating dryer for drying, the material temperature is 60-80℃, dry, and obtain whole granules.
[0047] Example 6 Investigation of the antibacterial activity of dandelion granules
[0048] Escherichia coli and Staphylococcus aureus were inoculated on MH agar medium and cultured at 37℃ for 24h. Single colonies were inoculated on MH broth medium and cultured at 37℃ for 24h. The culture was diluted with physiological saline to 1.0×10 5 CFU / ml.
[0049] Take a 96-well plate, add 100 μl of MH broth culture medium to each well, then add 100 μl of drug solution to each well, and then add 100 μl of the above bacterial solution to each well, and set up a positive control with bacterial solution but no drug and a negative control with culture medium only, mix each well on an oscillator, and culture at 37°C for 24 hours. The lowest drug concentration at which no bacteria grow clearly under a microscope is taken as the MIC.
[0050] Example 4 group: accurately weigh the dandelion particles prepared in Example 4, prepare a 200 mg / ml aqueous solution with water, and then dilute in equal proportions to prepare 100, 50, 25, 12.5, and 6.25 mg / ml aqueous solutions in sequence.
[0051] Example 5 group: accurately weigh the dandelion particles prepared in Example 5, prepare a 200 mg / ml aqueous solution with water, and then dilute it in equal proportions to prepare 100, 50, 25, 12.5, and 6.25 mg / ml aqueous solutions in sequence.
[0052] Arginine group: Accurately weigh arginine and prepare it into a 200 mg / ml aqueous solution with water, and then dilute it in equal proportions to prepare 100, 50, 25, 12.5, and 6.25 mg / ml aqueous solutions in sequence.
[0053] Xanthan gum group: accurately weigh xanthan gum and prepare it into a 200 mg / ml aqueous solution with water, and then dilute it in equal proportions to prepare 100, 50, 25, 12.5, and 6.25 mg / ml aqueous solutions in sequence.
[0054] Comparative Example Group: Accurately weigh the dandelion particles prepared in Group 6 of Example 1, prepare a 200 mg / ml aqueous solution with water, and then dilute in equal proportions to prepare 100, 50, 25, 12.5, 6.25 and 3.125 mg / ml aqueous solutions in sequence.
[0055] The specific results are as follows:
[0056] MIC (mg / ml) Escherichia coli Staphylococcus aureus Example 4 Group 6.25 25 Example 5 Group 12.5 50 Arginine group >200 >200 Xanthan gum group >200 >200 Comparative group 25 50
Claims
1. A method for preparing dandelion granules, comprising: include: 1) Take dandelion medicinal material, crush it, boil it with 12 times the volume of water for 2 hours, filter the decoction, add 10 times the volume of water for the second time, boil it for 2 hours, filter the decoction, and combine the two filtrates; 2) Add amino acids to the filtrate and stir evenly; let it stand for 2 hours, filter and concentrate to a clear paste with a relative density of 1.32 to 1.35 (measured at 80 to 85°C). 3) Add 5 parts of sucrose powder to 1 part of clear paste, granulate with ethanol, send the wet granules into a granulating dryer for drying, and the whole granules are obtained.
2. The method for preparing the dandelion granules according to claim 1, It is characterized in that The amino acid is one or more of arginine, histidine and lysine.
3. The method for preparing the dandelion granules according to claim 2, It is characterized in that The weight ratio of the amino acid to the dandelion medicinal material is 0.01-1%.
4. The method for preparing the dandelion granules according to claim 3, It is characterized in that The weight ratio of the amino acid to the dandelion medicinal material is 0.05-0.1%.
5. The method for preparing the dandelion granules according to claim 2, It is characterized in that The amino acid is arginine or histidine.
6. The method for preparing the dandelion granules according to claim 1, It is characterized in that In step 2), an anti-crystallization agent is added simultaneously with the addition of the amino acid.
7. The method for preparing the dandelion granules according to claim 6, It is characterized in that The anti-crystallization agent is xanthan gum.
8. The method for preparing the dandelion granules according to claim 6, It is characterized in that The weight ratio of the anti-crystallization agent to the amino acid is 1:0.5-2.
9. The dandelion granules obtained by the method for preparing the dandelion granules according to any one of claims 1 to 8.
10. Use of the dandelion granules as claimed in claim 9 in the preparation of antibacterial and anti-inflammatory drugs.
